Skip to main content
Caplight Logo









Gals Bio

Gals Bio

Private
HaifaHealthcare & Life Scienceshttps://tulipon.com/

Last Round

Grant

Sep 1, 2024

Total Funding Raised

$1.96M

Company Overview

Gals Bio is a femtech company that develops diagnostic menstrual products, including its flagship device Tulipon, which integrates biomarker monitoring with menstrual care.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Precision Medicine, D2C Brands

Business Model

B2C

Customer Profile

Hardware Sales, Data as a Service

AI Layer

Application

Keywords

femtechmenstrual healthhome diagnosticsbiomarker monitoringsmart tamponfem-wearablemenstrual cuphealth iotperiod trackerprecision medicinedtc healthmenstrual hygieneearly disease screeningvaginal healthai health app

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Gals Bio Comparables

Compare Gals Bio with similar companies based on industry and business-model similarity.

Gals Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Qvin
84%
Emm
83%
NextGen Jane
78%

Gals Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 1, 2024
CrowdfundingOct 13, 2023
CrowdfundingJan 1, 2022
Pre SeedApr 1, 2016

Key People

Founding team and executive leadership

Hilla Shaviv

CEO

Executive Team

Omer Shezifi

CTO and VP R&D

Executive Team

Gals Bio Investors

Notable investors and investment history

Gals Bio investors
InvestorRounds
PipelBizCrowdfunding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 1, 2024

    $370K raised from Horizon Europe

  • Oct 13, 2023

    Raised funds via Indiegogo platform.

Gals Bio Filings

Explore SEC and related filing metadata, where available.

Gals Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Gals Bio's valuation, stock price, and market status.

Is Gals Bio a public or private company?

Gals Bio is a private company.

What is the current stock price of Gals Bio?

Gals Bio is a private company with no public stock price. No recent secondary market data is available.

How much is Gals Bio worth (valuation)?

Valuation information for Gals Bio is not publicly available.

Can I buy Gals Bio stock?

Gals Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Gals Bio's last funding round?

Gals Bio's most recent funding round was Grant on September 1, 2024.

Who are the main investors in Gals Bio?

Key investors in Gals Bio include PipelBiz.

Will Gals Bio IPO soon?

No public IPO plans have been announced for Gals Bio.

How can I track Gals Bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Gals Bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHaifa
Employee Range8
Year Founded2016
Last FundingSep 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?